Skip to content
TrialScanner

NCT03613662

A Research Study to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102

Phase 2CompletedSMNRLeadSCLXCollaborator

Registry record

Lead sponsor
Semnur Pharmaceuticals, Inc.
Conditions
Lumbosacral Radicular Pain
Primary completion
Mar 15, 2019Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03613662 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03613662: A Research Study to Character... | TrialScanner